JPS53133627A - High purity deactivated vaccine for japanese encephalitis - Google Patents

High purity deactivated vaccine for japanese encephalitis

Info

Publication number
JPS53133627A
JPS53133627A JP4772177A JP4772177A JPS53133627A JP S53133627 A JPS53133627 A JP S53133627A JP 4772177 A JP4772177 A JP 4772177A JP 4772177 A JP4772177 A JP 4772177A JP S53133627 A JPS53133627 A JP S53133627A
Authority
JP
Japan
Prior art keywords
high purity
japanese encephalitis
deactivated vaccine
vaccine
deactivated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4772177A
Other languages
Japanese (ja)
Inventor
Hajime Nakamura
Hideaki Miyamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON SEIBUTSU KAGAKU KENKIYU
Original Assignee
NIPPON SEIBUTSU KAGAKU KENKIYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON SEIBUTSU KAGAKU KENKIYU filed Critical NIPPON SEIBUTSU KAGAKU KENKIYU
Priority to JP4772177A priority Critical patent/JPS53133627A/en
Publication of JPS53133627A publication Critical patent/JPS53133627A/en
Pending legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP4772177A 1977-04-25 1977-04-25 High purity deactivated vaccine for japanese encephalitis Pending JPS53133627A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4772177A JPS53133627A (en) 1977-04-25 1977-04-25 High purity deactivated vaccine for japanese encephalitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4772177A JPS53133627A (en) 1977-04-25 1977-04-25 High purity deactivated vaccine for japanese encephalitis

Publications (1)

Publication Number Publication Date
JPS53133627A true JPS53133627A (en) 1978-11-21

Family

ID=12783172

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4772177A Pending JPS53133627A (en) 1977-04-25 1977-04-25 High purity deactivated vaccine for japanese encephalitis

Country Status (1)

Country Link
JP (1) JPS53133627A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725546A (en) * 1984-08-09 1988-02-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method for purification of Japanese encephalitis virus
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
US7417136B1 (en) 1998-06-04 2008-08-26 The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725546A (en) * 1984-08-09 1988-02-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method for purification of Japanese encephalitis virus
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
US7417136B1 (en) 1998-06-04 2008-08-26 The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
US7521177B2 (en) 1998-06-04 2009-04-21 The United States Of America As Represented By The Department Of Health And Human Services Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence
US7632510B2 (en) 1998-06-04 2009-12-15 The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
US7662394B2 (en) 1998-06-04 2010-02-16 The United States Of America As Represented By The Department Of Health And Human Services Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence
US8105609B2 (en) 1998-06-04 2012-01-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
US8221768B2 (en) 1998-06-04 2012-07-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
US8232379B2 (en) 1998-06-04 2012-07-31 The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
US8728488B2 (en) 1998-06-04 2014-05-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

Similar Documents

Publication Publication Date Title
GB2009771B (en) Vaccine
YU199478A (en) Process for preparing triphenylalkene derivatives
HU174622B (en) Process for preparing furocoumarins
PT68978A (en) Process for preparing peptide derivatives
GB2001530B (en) Vaccine
ZA78421B (en) New vaccine
PT67615B (en) Process for preparing oxadiazolopyrimidine derivatives
HU177722B (en) Process for preparing 14-amino-morfine derivatives
PT68752A (en) Process for preparing novel 2-imino-imidazolidine derivatives
JPS53103430A (en) Phenylamidine derivatives
AU3797378A (en) Paramyxovirus vaccine
PT67614B (en) Process for preparing oxadiazolopyrimidine derivatives
JPS53148632A (en) Vacuum type timing unit
YU303778A (en) Process for preparing antiviral tetracyclononane derivatives
JPS53133627A (en) High purity deactivated vaccine for japanese encephalitis
GB1537867A (en) Process for preparing 4-acylamino-piperidine derivatives
HU178247B (en) Process for preparing benzolsulphonyl-carbamide derivatives
AU3966678A (en) Continuous vacuum crystallisers
JPS5480408A (en) Comosite vaccine
HU175776B (en) Process for preparing methylamine derivatives
GB1552869A (en) Process for obtaining high purity isobytlene
HU179711B (en) Process for preparing steroid-spiro-oxazolidinone derivatives
PT67635A (en) Process for preparing everninomicin derivatives
AU4218978A (en) Indexing means
YU40328B (en) Process for obtaining new 3-beta-subst.-18-beta-oleane-9-one-30-oleic acic derivatives